Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, People's Republic of China.
Cell Death Dis. 2013 Aug 1;4(8):e746. doi: 10.1038/cddis.2013.242.
The formulation of quercetin nanoliposomes (QUE-NLs) has been shown to enhance QUE antitumor activity in C6 glioma cells. At high concentrations, QUE-NLs induce necrotic cell death. In this study, we probed the molecular mechanisms of QUE-NL-induced C6 glioma cell death and examined whether QUE-NL-induced programmed cell death involved Bcl-2 family and mitochondrial pathway through STAT3 signal transduction pathway. Downregulation of Bcl-2 and the overexpression of Bax by QUE-NL supported the involvement of Bcl-2 family proteins upstream of C6 glioma cell death. In addition, the activation of JAK2 and STAT3 were altered following exposure to QUE-NLs in C6 glioma cells, suggesting that QUE-NLs downregulated Bcl-2 mRNAs expression and enhanced the expression of mitochondrial mRNAs through STAT3-mediated signaling pathways either via direct or indirect mechanisms. There are several components such as ROS, mitochondrial, and Bcl-2 family shared by the necrotic and apoptotic pathways. Our studies indicate that the signaling cross point of the mitochondrial pathway and the JAK2/STAT3 signaling pathway in C6 glioma cell death is modulated by QUE-NLs. In conclusion, regulation of JAK2/STAT3 and ROS-mediated mitochondrial pathway agonists alone or in combination with treatment by QUE-NLs could be a more effective method of treating chemical-resistant glioma.
槲皮素纳米脂质体(QUE-NLs)的配方已被证明可以增强 C6 神经胶质瘤细胞中 QUE 的抗肿瘤活性。在高浓度下,QUE-NLs 诱导细胞坏死性死亡。在这项研究中,我们探讨了 QUE-NL 诱导的 C6 神经胶质瘤细胞死亡的分子机制,并研究了 QUE-NL 诱导的程序性细胞死亡是否通过 STAT3 信号转导途径涉及 Bcl-2 家族和线粒体途径。QUE-NL 下调 Bcl-2 和 Bax 的过表达支持 Bcl-2 家族蛋白在 C6 神经胶质瘤细胞死亡的上游参与。此外,在 C6 神经胶质瘤细胞中暴露于 QUE-NLs 后,JAK2 和 STAT3 的激活发生改变,表明 QUE-NLs 通过 STAT3 介导的信号通路通过直接或间接机制下调 Bcl-2 mRNAs 表达并增强线粒体 mRNAs 的表达。坏死和凋亡途径有几个共同的成分,如 ROS、线粒体和 Bcl-2 家族。我们的研究表明,线粒体途径和 JAK2/STAT3 信号通路在 C6 神经胶质瘤细胞死亡中的信号交叉点受 QUE-NLs 调节。总之,单独或联合 QUE-NLs 治疗调节 JAK2/STAT3 和 ROS 介导的线粒体途径激动剂可能是治疗化学抗性神经胶质瘤的更有效方法。